How the MDR and UKCA regulation will impact your sales

We sales & marketing people are in general not very much interested in regulatory stuff. However if you do not want your sales in the UK and Europe to be disrupted, it is important to take knowledge of the changes that will take place very soon.

There are already numerous articles about the changes, guidelines and protocols of the MDR regulations, so I won’t bore you with it. A few websites you can find more information on are listed below the sections.

MDR – Selling your medical device into Europe through distributors / importers

For medical device manufacturers selling into Europe under the CE mark, changes will take place in the liabilities and responsibilities of the manufacturer and the economic operators (European importers and distributors, EO) (figure 1).

The goal of this change is to make each entity responsible and serve as a control / safety check the products introduced in the European market and organizations involved are compliant to the MDR.

Your distributor may be your importer, you may be the importer or you may choose to have a separate importer and distributor. There are multiple ways to organize which pro’s and con’s depending on your agreements, size of your European presence and resources.

It is the Manufacturer’s responsibility to map out the EO chain to define the operating identities in Europe. Failing to do so will put the business at significant risk of compliance non-conformities.

European Importer changes:

Importers, like distributors had no regulatory obligations. Under the new MDR the responsibilities are:

Responsible for conducting specific checks necessary to ensure the products they represent are compliant by checking CE marks, Declarations of conformity, registration in EUDAMED and by identifying the manufacturer and Authorized Representative

  • Ensure systems and processes are in place that comply with the new requirement to:
    • Keep a register of complaints;
    • Non-conforming devices;
    • Recalls and withdrawals to enable investigation by the competent authorities, if required.
    • Forward complaint information to manufacturers
    • Notification system for non-compliant devices to the manufacturer, competent authority and authorized representative
    • Ensure storage and maintenance conditions are respected and must check decides are labeled and always matched to their instructions for use (IFUs) and UDI labels are present where needed

  • Importers must ensure devices are labelled with information allowing for Importer identification:
    • Importer’s name
    • Importers trade name or trademark
    • Registered place of business
    • Address for contact
    • No obscuration of manufacturer label

This transition and verifying whether the manufacturer located outside the EU has the technical, scientific and financial capacity to continue manufacturing an EU compliant device.

European distributor changes:

Distributors did not face any regulatory obligations in the past either. In the new MDR regulations they are jointly and severally liable.

  • Ensure storage or transport conditions comply with those set out by the manufacturer
  • Verify Instruction For Use (IFU) are included with each device and the CE mark, declaration of conformity and any UDI’s are present;
  • Taking corrective action and notification to the Competent authority, manufacturer and authorized representative when a device presents a serious risk or is falsified
  • Authority with information, samples and access to the device
  • Forwarding complaints and keep a register of: complaints, non-conforming devices, recalls and withdrawals
  • The main additional role of the distributor is to include verification processes that verifies: the CE mark, EU declaration of conformity, IFU’s, compliance of importer and the right UDI is assigned to the device by the manufacturer.

The UKCA Mark

The UKCA (UK conformity assessed) mark is the newly introduced UK product marking that will be used for certain goods, including medical devices, being placed on the Great Britain market.

Manufacturers of devices that will be placed on the Great Britain market will be able to use this mark starting from the end of the transition period, i.e. 1 January 2021. The MHRA will continue to recognize the CE mark until the 1st of July 2023 for devices placed on the Great Britain market that have been CE marked under and, fully conform with, any of the current Directives or incoming Regulations of the EU for Medical Devices (Active implantable medical devices) and IVD devices.

The UKCA mark will not, however, be recognized in the EU, EEA and NIR markets and as such it will not be interchangeable with the CE mark outside of Great Britain. To this effect, devices that will be placed on those markets will continue to need a CE mark for this purpose. From the 1st of July 2023, the UKCA will be the only marking recognized in Great Britain and as such all manufacturers will need to meet the relevant requirements and place the UKCA mark on their devices.

blog-hea-quote_51072726

Labelling requirements    
Devices placed on the Great Britain market after the 1st of January 2021 may either carry the CE mark or the UKCA mark, depending on which legislation has been used as the basis for the conformity assessment and certification of the device. The number of the NB or UK approved body will also have to appear on the label, where applicable.

Devices that will carry a valid CE mark, at the end of the transition period, will not be required to be re-labeled with the UKCA until the 1st of July 2023. During this time, they may be placed on the Great Britain market with the CE mark on their label. Devices that carry a dual mark on their label can continue to be sold on the Great Britain market after the 1st of July 2023 by virtue of carrying the UKCA mark, irrespective of the CE mark also appearing on the label.

The presented proposals will take effect through legislative changes introduced later this year, and are therefore still subject to parliamentary approval.

 

For more information feel free to reach out to us for more information or your regulatory partners. www.mdlaw.eu contains all the documents and tools you need to comply with the UKCA.

 

Recommendations and challenges

These are all new processes for your distributors and importers. It is important to educate them on these changes as many are still not aware.

Discuss and requalify their capabilities and resources to determine whether they will and can comply. If in an audit it comes to light, they are not in compliance, you as a manufacturer will be affected due to not being able to use this channel and experience disruptions in sales.

Build in annual performance reviews that evaluates these processes and involve the regulatory responsible person as well. Keep record of these meetings and make sure the documents required for distributors and importers are easy accessible.

Above all it is important there is a contract in place that is compliant with the MDR and formalizes all agreements between the parties.

For a draft contract, feel free to reach out.

Schedule a meeting

More information can also be found on www.mdlaw.eu. A platform for all documentation and tools you need to be compliant.

Sources for more information on the MDR
Med-Tech news
MPO-Mag

Maetrics
Obelis
TUV-Sud

 

Our latest blogs: